Perhaps timely catching Phathom Pharmaceuticals Inc (PHAT) would be a good idea

With 0.86 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.0 million shares. The 52-week range on PHAT shows that it touched its highest point at $19.71 and its lowest point at $5.15 during that stretch. It currently has a 1-year price target of $24.62. Beta for the stock currently stands at 0.45.

Price Performance and Earnings:

Three-month performance dropped to -37.79% while six-month performance fell -65.77%. The stock lost -47.85% in the past year, while it has lost -31.28% so far this year. A look at the trailing 12-month EPS for PHAT yields -5.69 with Next year EPS estimates of -4.25. For the next quarter, that number is -1.21. This implies an EPS growth rate of -34.71% for this year and 19.65% for next year. EPS is expected to grow by 22.16% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -137.06%.

Float and Shares Shorts:

At present, 68.32 million PHAT shares are outstanding with a float of 38.09 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for PHAT since 10 analysts follow the stock currently. There are 6 analysts who recommend BUY ratings, while 2 suggest SELL ratings. Of the remaining analysts, 2 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$3.82111 being high and -$6.81276 being low. For PHAT, this leads to a yearly average estimate of -$5.29391.

Summary of Insider Activity:

Insiders traded PHAT stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has remained unchanged to 0 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 0 while 0 shares were sold.